Clinical biomarkers for hypoxia targeting
Authors:
- 16 May 2008
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 27 (3) , 351-362
Abstract
Tumor hypoxia or a reduction of the tissue oxygen tension is a key microenvironmental factor for tumor progression and treatment resistance in solid tumors. Because hypoxic tumor cells have been demonstrated to be more resistant to ionizing radiation, hypoxia has been a focus of laboratory and clinical research in radiation therapy for many decades. It is believed that proper detection of hypoxic regions would guide treatment options and ultimately improve tumor response. To date, most clinical efforts in targeting tumor hypoxia have yielded equivocal results due to the lack of appropriate patient selection. However, with improved understanding of the molecular pathways regulated by hypoxia and the discovery of novel hypoxia markers, the prospect of targeting hypoxia has become more tangible. This chapter will focus on the development of clinical biomarkers for hypoxia targeting.Keywords
This publication has 126 references indexed in Scilit:
- Fluorine-18-Labeled Fluoromisonidazole Positron Emission and Computed Tomography-Guided Intensity-Modulated Radiotherapy for Head and Neck Cancer: A Feasibility StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancerBritish Journal of Cancer, 2007
- Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinomaLung Cancer, 2006
- Plasma Osteopontin Is an Independent Prognostic Marker for Head and Neck CancersJournal of Clinical Oncology, 2006
- Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human CancersPLOS Medicine, 2006
- Measurement of Glut-1 Expression Using Tissue Microarrays to Determine a Race Specific Prognostic Marker for Breast CancerBreast Cancer Research and Treatment, 2005
- Lack of Correlation between Expression of HIF-1α Protein and Oxygenation Status in Identical Tissue Areas of Squamous Cell Carcinomas of the Uterine CervixCancer Research, 2004
- Hypoxia‐inducible factor‐1α in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathwaysInternational Journal of Cancer, 2004
- Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resectionEuropean Journal of Cancer, 2004
- Hypoxic Sensitizers — Implications for Radiation TherapyNew England Journal of Medicine, 1979